Systemic corticosteroids for the treatment of COVID‐19: Equity‐related analyses and update on evidence

C Wagner, M Griesel, A Mikolajewska… - The Cochrane …, 2022 - pmc.ncbi.nlm.nih.gov
Background Systemic corticosteroids are used to treat people with COVID‐19 because they
counter hyper‐inflammation. Existing evidence syntheses suggest a slight benefit on …

Pathophysiology and clinical management of coronavirus disease (COVID-19): a mini-review

Y Zhu, L Sharma, D Chang - Frontiers in Immunology, 2023 - frontiersin.org
An unprecedented global pandemic caused by a novel coronavirus named SARS-CoV-2
has created a severe healthcare threat and become one of the biggest challenges to human …

An update on management of adult patients with acute respiratory distress syndrome: an official American Thoracic Society Clinical Practice Guideline

N Qadir, S Sahetya, L Munshi, C Summers… - American journal of …, 2024 - atsjournals.org
Background: This document updates previously published Clinical Practice Guidelines for
the management of patients with acute respiratory distress syndrome (ARDS), incorporating …

Corticosteroids for COVID-19 therapy: potential implications on tuberculosis

R Gopalaswamy, S Subbian - International journal of molecular sciences, 2021 - mdpi.com
On 11 March 2020, the World Health Organization announced the Corona Virus Disease-
2019 (COVID-19) as a global pandemic, which originated in China. At the host level, COVID …

Safety and efficacy of corticosteroids in ARDS patients: a systematic review and meta-analysis of RCT data

X Chang, S Li, Y Fu, H Dang, C Liu - Respiratory Research, 2022 - Springer
Purpose Acute respiratory distress syndrome (ARDS) is an acute and critical disease among
children and adults, and previous studies have shown that the administration of …

Use of steroids in COVID-19 patients: A meta-analysis

M Thakur, AK Datusalia, A Kumar - European Journal of Pharmacology, 2022 - Elsevier
Background Emerging reports have shown the benefits of steroids in hospitalized COVID-19
patients as life-saving drugs. However, the use of steroids in COVID-19 patients is confusing …

Systemic corticosteroids for the treatment of COVID‐19

Cochrane Haematology Group… - Cochrane Database …, 1996 - cochranelibrary.com
Background Systemic corticosteroids are used to treat people with COVID‐19 because they
counter hyper‐inflammation. Existing evidence syntheses suggest a slight benefit on …

Efficacy of COVID-19 treatments: a Bayesian network meta-analysis of randomized controlled trials

C Zhang, H **, YF Wen, G Yin - Frontiers in Public Health, 2021 - frontiersin.org
Background: We provided a comprehensive evaluation of efficacy of available treatments for
coronavirus disease 2019 (COVID-19). Methods: We searched for candidate COVID-19 …

The efficacy of oral/intravenous corticosteroid use in COVID-19 patients: a systematic review

IR Latarissa, F Rendrayani, GN Iftinan… - Journal of …, 2024 - Taylor & Francis
The COVID-19 pandemic is prompting extensive investigation into potential treatments,
including the use of corticosteroids to manage inflammation and mitigate severe disease …

Daily monitoring of viral load measured as SARS-CoV-2 antigen and RNA in blood, IL-6, CRP and complement C3d predicts outcome in patients hospitalized with …

CL Brasen, H Christensen, DA Olsen… - Clinical Chemistry and …, 2021 - degruyter.com
Objectives We hypothesized that the amount of antigen produced in the body during a
COVID-19 infection might differ between patients, and that maximum concentrations would …